Emergency Room Wait Times
Home > Clinical Trials > Clinical Trial Details
<< Back to Results
Request Additional Trial InformationFull Trial Details: ClinicalTrials.gov
Condition: Renal Cancer Study Type: Interventional Phase: Phase III Study Start Date: 10/13/2016Study Completion Date: 01/15/2020
This is a multicenter, randomized, open-label, Phase 3 study to compare the efficacy and safety of lenvatinib in combination with everolimus (Arm A) or pembrolizumab (Arm B) versus sunitinib (Arm C) as first-line treatment in participants with advanced renal cell carcinoma.
Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.
Set Your Location
Setting your location helps us to show you nearby providers and locations based on your healthcare needs.